Alto Neuroscience (ANRO) Other Non Operating Income (2025)

Alto Neuroscience (ANRO) reported Other Non Operating Income of -$681000.0 for Q1 2025.

Alto Neuroscience (ANRO) Other Non Operating Income (2025) Analysis & Trends

Alto Neuroscience (ANRO) has 1 years of Other Non Operating Income data on file, last reported at -$681000.0 in Q1 2025.

For the quarter ending Q1 2025, Other Non Operating Income changed N/A year-over-year to -$681000.0; the trailing twelve-month figure through Dec 2025 stood at -$681000.0 (changed N/A YoY), and the FY2025 full-year result was -$681000.0, changed N/A from the prior year.
Other Non Operating Income steadied at -$681000.0 in Q1 2025.
In the past five years, Other Non Operating Income ranged from a high of -$681000.0 in Q1 2025 to a low of -$681000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Alto Neuroscience	881.86 Mn	881.86 Mn	-

Download Data

Date	Value
Mar 31, 2025	-681,000.00